Showing results (1801-1810 of 1,908) with videos related to

Sort By:
Pageof 191
Gastroenterology|March 12, 2014
Loss-of-function of the voltage-gated sodium channel NaV1.5 (channelopathies) in patients with irritable bowel syndromeArthur Beyder, Amelia Mazzone, Peter R Strege, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 28, 2021
Surveillance for hepatocellular carcinoma with a 3-months interval in "extremely high-risk" patients does not further improve survivalFilippo Pelizzaro, Giulia Peserico, Marco D'Elia, et al.
The American Journal of Gastroenterology|April 25, 2022
An Objective Comparison of Vedolizumab and Ustekinumab Effectiveness in Crohn's Disease Patients' Failure to TNF-Alpha InhibitorsSara Onali, Daniela Pugliese, Flavio Andrea Caprioli, et al.
Liver Cancer|May 12, 2021
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial ChemoembolizationClaudia Campani, Alessandro Vitale, Gabriele Dragoni, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 8, 2025
Absence of Viral Replication Is Associated With Improved Outcome in Anti-HCV-Positive Patients With Hepatocellular CarcinomaEdoardo G Giannini, Andrea Pasta, Maria Corina Plaz Torres, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 10, 2024
Sorafenib and Metronomic Capecitabine in Child-Pugh B patients with advanced HCC: A real-life comparison with best supportive careBenedetta Stefanini, Laura Bucci, Valentina Santi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 6, 2020
Monofocal hepatocellular carcinoma: How much does size matter?Filippo Pelizzaro, Barbara Penzo, Giulia Peserico, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 28, 2019
The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort studyAlessandro Vitale, Fabio Farinati, Timothy M Pawlik, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|January 21, 2018
Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study GroupAlessandro Vitale, Quirino Lai, Fabio Farinati, et al.
Bioorganic & Medicinal Chemistry Letters|September 21, 2010
Discovery of N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4,5-dihydro-6H-[1,2,4]triazolo[4,3-a][1,5]benzodiazepin-6-yl]-N-isopropylacetamide, an orally active, gut-selective CCK1 receptor agonist for the potential treatment of obesityRichard L Elliott, Kimberly O Cameron, Janice E Chin, et al.
Pageof 191